Key result
PMBV improves LVGLS in severe rheumatic mitral stenosis, though ~29% lack meaningful recovery.
Why the study?
The regional pattern of left ventricular strain recovery after percutaneous mitral balloon valvuloplasty and its prognostic implications in severe rheumatic mitral stenosis remain uncertain.
Does percutaneous mitral balloon valvuloplasty improve left ventricular global longitudinal strain in patients with severe rheumatic mitral stenosis?
Cohort (n=190)
Single-blind
No
Does percutaneous mitral balloon valvuloplasty improve left ventricular global longitudinal strain in patients with severe rheumatic mitral stenosis?
In severe rheumatic mitral stenosis, PMBV leads to an immediate, predominantly load-mediated improvement in LV longitudinal mechanics, but this strain recovery does not independently predict long-term clinical outcomes.
GLS non-recovery after PMBV does not predict events in rheumatic MS; leaves open strain imaging's added prognostic value beyond standard factors.
In severe rheumatic mitral stenosis (MS), left ventricular (LV) systolic function is often considered preserved based on ejection fraction. However, longitudinal myocardial mechanics may be impaired and may improve after relief of inflow obstruction. The regional pattern of strain recovery following percutaneous mitral balloon valvuloplasty (PMBV), and its prognostic implications remain uncertain. To characterize global and regional LV strain response following PMBV, identify determinants of limited strain recovery, and evaluate its association with long-term outcomes. In 190 patients with severe symptomatic MS undergoing PMBV, LVGLS was measured by speckle-tracking echocardiography before and within 48 h after intervention. Absence of meaningful recovery was defined as ≤ 15% relative GLS improvement. The secondary endpoint was cardiovascular death or subsequent mitral valve replacement. PMBV significantly increased mitral valve area and reduced transmitral gradients, with concomitant improvement in GLS despite unchanged ejection fraction. Strain recovery demonstrated a distinct basal-to-apical gradient, with the greatest improvement in basal segments. In 29% of patients, absent GLS improvement was observed. Limited recovery was independently associated with larger baseline valve area, reduced leaflet displacement, lower pre-procedural left atrial pressure, and higher post-procedural pulmonary artery pressure. Over 48 months of follow-up, adverse outcomes were independently predicted by age, advanced NYHA class, smaller post-procedural valve area, higher residual gradient, and greater mitral regurgitation severity. Absence of GLS improvement was not associated with long-term events. In severe rheumatic MS, PMBV leads to an immediate improvement in LV longitudinal mechanics, characterized by a distinct basal predominance of recovery. This response appears largely load-mediated and does not independently translate into improved prognosis, which is primarily determined by procedural success and the degree of residual valve obstruction.
No takes yet. Share an insight, caveat, or question.
Chavez et al. (2026) conducted a cohort in Severe rheumatic mitral stenosis (n=190). Percutaneous mitral balloon valvuloplasty vs. Baseline (pre-procedure) was evaluated on Absence of meaningful left ventricular functional recovery (≤ 15% relative improvement in LVGLS compared with baseline). Percutaneous mitral balloon valvuloplasty improved left ventricular global longitudinal strain from 16.2% to 20.3% in patients with severe rheumatic mitral stenosis, although 29% of patients demonstrated an absence of meaningful strain recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: